Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

[Antimicrobial peptides: a potential arsenal against HIV infection].

Castañeda-Delgado JE, Cervantes-Villagrana AR, Rivas-Santiago B.

Invest Clin. 2012 Mar;53(1):71-83. Review. Spanish.

PMID:
22524110
2.

Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides.

Cole AM.

Expert Opin Ther Targets. 2003 Jun;7(3):329-41. Review.

PMID:
12783570
3.

Compounds with anti-HIV activity from plants.

Houghton PJ.

Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):601-4. Review.

PMID:
9015492
4.

Targeting strategies for Human immunodeficiency virus: a combinatorial approach.

Saxena SK, Gupta A, Bhagyashree K, Saxena R, Arora N, Banerjee AK, Tripathi AK, Chandrasekar MJ, Gandhi N, Nair MP.

Mini Rev Med Chem. 2012 Mar;12(3):236-54. Review.

PMID:
22356194
5.

[HIV infection. Virus resistance: development and prevention].

Link R, Miller V, Fätkenheuer G, Manegold C, Harrer T.

Med Monatsschr Pharm. 1999 Mar;22(3):86-8. German. No abstract available.

PMID:
10223868
6.

Antivirals in the context of HIV disease.

Wood MJ.

J Antimicrob Chemother. 1996 May;37 Suppl B:97-112. Review.

PMID:
8818833
7.

Antimicrobial peptide microbicides targeting HIV.

Cole AM.

Protein Pept Lett. 2005 Jan;12(1):41-7. Review.

PMID:
15638802
8.

[The HIV replication cycle. Established therapeutic targets and potential targets].

Alcamí J.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:3-10. Review. Spanish.

PMID:
19572419
9.

HIV chemotherapy.

Richman DD.

Nature. 2001 Apr 19;410(6831):995-1001. Review.

PMID:
11309630
10.

[Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches].

Manegold C.

MMW Fortschr Med. 2000 Mar 13;142 Suppl 1:34-9. German.

PMID:
10863308
11.

[German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)].

Brockmeyer NH; Deutschen AIDS-Gesellschaft (DAIG); Osterreichischen AIDS-Gesellschaft (OAG).

Dtsch Med Wochenschr. 2003 May 9;128 Suppl 1:S7-18. German. No abstract available.

PMID:
12736863
12.

Stages of HIV replication and targets for therapeutic intervention.

Tözsér J.

Curr Top Med Chem. 2003;3(13):1447-57. Review.

PMID:
14529520
13.

Human immunodeficiency virus postexposure prophylaxis for adolescents and children.

Merchant RC, Keshavarz R.

Pediatrics. 2001 Aug;108(2):E38.

PMID:
11483848
14.

Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.

De Clercq E, Schols D.

Antivir Chem Chemother. 2001;12 Suppl 1:19-31.

PMID:
11594685
15.

Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery.

Sperstad SV, Haug T, Blencke HM, Styrvold OB, Li C, Stensvåg K.

Biotechnol Adv. 2011 Sep-Oct;29(5):519-30. doi: 10.1016/j.biotechadv.2011.05.021. Epub 2011 Jun 13. Review.

PMID:
21683779
16.

New drug makes host cell machinery unavailable to HIV.

Senior K.

Mol Med Today. 1999 Jun;5(6):234-5. No abstract available.

PMID:
10366815
17.

HIV resistance and the developing world.

Gupta RK, Pillay D.

Int J Antimicrob Agents. 2007 May;29(5):510-7. Epub 2007 Mar 7. Review.

PMID:
17346940
18.

Hydroxyurea to inhibit human immunodeficiency virus-1 replication.

Romanelli F, Pomeroy C, Smith KM.

Pharmacotherapy. 1999 Feb;19(2):196-204. Review.

PMID:
10030769
19.

The challenge of finding a cure for HIV infection.

Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ.

Science. 2009 Mar 6;323(5919):1304-7. doi: 10.1126/science.1165706. Review.

PMID:
19265012
20.

Combination therapy in the management of HIV infection.

Vella S, Franca Pirillo M.

Methods Find Exp Clin Pharmacol. 1996;18 Suppl C:23-6. Review. No abstract available.

PMID:
9003571

Supplemental Content

Support Center